Melexis NV (LON:0FA0)

Ligand Pharmaceuticals Revenue

Melexis NV had revenue of 211.59M EUR in the quarter ending June 30, 2025, a decrease of -13.89%. This brings the company's revenue in the last twelve months to 855.10M, down -13.33% year-over-year. In the year 2024, Melexis NV had annual revenue of 932.81M, down -3.27%.

• Revenue (ttm): 855.10M EUR
• Revenue Growth: -13.33%
• P/S Ratio: 3.13
• Revenue / Employee: 428.62K EUR
• Employees: 1,995
• Market Cap: 2.30B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	932.81M	-31.49M	-3.27%
Dec 31, 2023	964.30M	128.14M	15.32%
Dec 31, 2022	836.16M	192.37M	29.88%
Dec 31, 2021	643.79M	136.27M	26.85%
Dec 31, 2020	507.52M	20.66M	4.24%